Revolutionizing Infection Prevention in Hospitals
Hospital-acquired infections (HAIs) are among the most costly and preventable complications in healthcare—adding billions in avoidable expenses each year. Leading guidelines now recognize nasal decolonization as essential for high-risk surgeries, such as orthopedic and cardiothoracic procedures.
Ondine Biomedical’s light-activated photodisinfection platform technology targets a critical source of hospital-acquired infections using a fast, painless, non-antibiotic approach. Our lead product, Steriwave®, delivers a simple 5-minute nasal treatment that helps protect patients, reduce complications, and free up hospital resources.
- Kills a broad spectrum of pathogens (bacterial, viral, fungal), including superbugs
- Immediately effective
- Promotes high compliance
- Non-resistance forming
- Single application lasts days, not hours
- Painless and safe for repetitive use
Steriwave is already in use at leading hospitals and gaining traction internationally.
To receive news and updates on our progress, including upcoming milestones, please fill out the form on the right.
First hand experiences with Steriwave nasal photodisinfection:
